The legislation would have put patients at risk, slowed the development of effective stem cell therapies, and blocked the Food and Drug Administration (FDA) from access to crucial data about the safety and effectiveness of new medical treatments.Full story
- 12 March, 2018
Recipients of the 2018 awards will be presented at the society’s annual meeting, 20-23 June in Melbourne, Australia: ISSCR Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award.Full story
- 14 March, 2018
Message from the President
Hubrecht Institute, the Netherlands
Scientific excellence is at the core of the ISSCR and is reflected each year in the annual meeting, where exceptional science is shared, discussed, and deliberated. This exchange is key to advancing the scientific dialogue that moves the field forward.
Since its inception sixteen years ago, the ISSCR has been hosting annual meetings to share and celebrate outstanding stem cell research and highlight it for the rest of the world. The 2018 program in Melbourne, Australia continues that tradition, featuring groundbreaking research presented in plenary, concurrent, and poster sessions.
stem cell researchTake a closer look
What Can We Learn from the (Tasmanian) Devil?
Why might stem cell scientists care about a small marsupial unique to Tasmania, a small island off the coast of Australia? Good question. Tasmanian devils are afflicted with a unique type of cancer that is transmitted from animal to animal – a disease that is threatening existence of the species. Scientists are studying stem cells from these animals in the hopes that they can learn how the cancer spreads and develop life-saving treatments to save this marsupial from extinction.
Stem Cells in the News
Media highlights in the field of stem cell research and its translation to the clinic.
8 March, CNN
5 March, Forbes
27 February, Scientific American
26 February, TheScientist
A sampling of recent stem cell research commentaries, articles, and resources.
Featured Current Protocols in Stem Cell Biology Article
hPSC-derived Midbrain Dopaminergic Neurons Generated in a Scalable 3-D Biomaterial. Maroof M. Adil, David V. Schaffer (2018).Current Prot. Stem Cell Biol. p. 2D.21.1-2D.21.17.
Tissue stiffening coordinates morphogenesis by triggering collective cell migration in vivo. Barriga, E. H., Franze, K., Charras, G. and Mayor, R. (2018), Nature , 554, 523-527.
- , Melbourne
Seeking a job? Have a job opening? the ISSCR Job Board gives members discounts on job postings here and in the monthly Pulse e-newsletter.
Other Stem Cell Events
Opportunities for researchers from around the world to explore the latest discoveries in stem cell science and regenerative medicine.
- , Olympic Valley
Stem Cell CoursesView All
- , Cambridge
ISSCR and policy news from around the world.
8 March, New England Journal of Medicine
Balancing Safety and Innovation for Cell-Based Regenerative Medicine
2 March, Regulatory Focus
May on Brexit: UK Should Remain Part of EMA
28 February, Nature
Canadian Science Wins Billions in New Budget
21 February, National Public Radio
Doctors in China Lead Race to Treat Cancer by Editing Genes
Learn about ISSCR colleagues in the stem cell field from around the world.
Nils Pfaff, PhD
What is the current focus of your research, and what do you find most rewarding about your work?
I am currently working in preclinical research in the Pharmaceuticals Division of Bayer. Apart from establishing iPSC-derived cells for target identification and validation, the main focus is in vivo pharmacology mostly in the therapeutic areas thrombosis and hemophilia. I really like the application-driven way of working in the (pharma) industry. It is great being involved in projects that always have the goal to improve the life of patients and being able to actually move these projects forward. It’s also fascinating to see how complex developing a new drug actually is and there is something new to learn every day.
What led you to become a scientist and to stem cell research?
I’ve always been interested in science. Back in high school I participated in a science club, which allowed me to work on smaller projects in a university lab during some of the vacations. At first I decided to study medicine but somehow realized I didn’t want to become a physician. That’s why I enrolled for Molecular Medicine (at Göttingen University, Germany), which turned out to be a great combination of science and medicine. When I started my PhD in 2008, iPS cells really were the hottest topic in biomedical research and the possibility to turn a skin cell into a stem cell into a blood/neuronal/cardiac cell was (and still is) just thrilling.
How do you spend your free time?
I regularly play football (soccer for the US folks…) and force myself to go running at least once a week. I also enjoy cooking (end eating, of course) a lot and have become a bit of a wine geek lately as well. Trying to stay in touch with friends and family is also very important for me.
What is something your peers would be surprised to learn about you?
I am a guitarist in a heavy metal band (the long hair is gone, though…) and regularly go to metal concerts and festivals.
What do you most value about your membership with the ISSCR?
Being member of the ISSCR is the best and easiest way to stay connected with the entire stem cell community and to permanently keep track of this still rapidly evolving field. Going to the annual meetings is always fun because you meet colleagues you haven’t seen for a whole year in most of the cases. Of course, the science presented is fascinating every time. Working in the ISSCR Industry Committee is a great way to discuss the industry’s perspective on translational aspects with the community – I think this dialogue is essential to bring effective stem cell-based therapies to patients.